ÂÜÀòÂÒÂ×

Monika Kott is an experienced professional in healthcare investment and business development, currently serving as a Synergy Partner at Unicorn Next since October 2024, focusing on healthcare investment opportunities in Europe for Indian and South East Asian capital. Additionally, Monika acts as a Business Development Advisor for a stealth mode startup in the fertility space and offers business consulting services through Independent Advisory. Monika's past roles include Project and Operations Director at Alchemab Therapeutics Ltd, where contributions began at the Seed Stage, and various strategic consulting positions in companies such as Mölnlycke and Candesic. Monika's educational background includes an MSc in International Health Management from Imperial College London and a BSc in Accounting and Finance from The London School of Economics, complemented by studies at renowned institutions including Harvard University and the University of Geneva.